• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Medtronic Europe Sarl Claria MRI CRT-D SureScan; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Medtronic Europe Sarl Claria MRI CRT-D SureScan; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number DTMA1D4
Medical Device Problem Codes Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Device Sensing Problem (2917)
Health Effect - Clinical Code Shock from Patient Lead(s) (3162)
Date of Event 07/18/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient received potentially inappropriate anti-tachycardia pacing (atp) and high voltage therapy from the cardiac resynchronization therapy defibrillator (crt-d) for atrial fibrillation (af) with rapid ventricular response that was detected as ventricular fibrillation (vf).The right atrial (ra) lead exhibited undersensing that resulted in termination of atrial tachycardia/atrial fibrillation (at/af) events.The crt-d and ra lead remain in use.No further patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Continuation of d10: 407652 lead implant date (b)(6)2005, 4195 lead implant date:  (b)(6)2014 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Claria MRI CRT-D SureScan
Common Device Name
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
Medtronic Europe Sarl
route du molliau 31
case postale
tolochenaz vaud 1131
SZ  1131
Manufacturer (Section G)
Medtronic Europe Sarl
route du molliau 31
case postale
tolochenaz vaud 1131
SZ   1131
Manufacturer Contact
gerard torenvliet
8200 coral sea st ne
mounds view, MN 55112--439
+1(763)526-9277
MDR Report Key50146307
Report Number9614453-2026-03144
Device Sequence Number13404784
Product Code NIK
UDI-Device Identifier00763000059583
UDI-Public(01)00763000059583(17)250728
Combination Product (Y/N)N
Initial Reporter StateOK
Initial Reporter CountryUS
PMA/510(K) Number
P010031
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 08/05/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Operator of Device Lay User/Patient
Device Expiration Date07/28/2025
Device Model NumberDTMA1D4
Device Catalogue NumberDTMA1D4
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/18/2026
Initial Report FDA Received Date08/05/2026
Date Device Manufactured01/30/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
6935M LEAD
Outcome Attributed to Adverse Event Life Threatening;
Patient Age73 YR
Patient SexMale
Patient Weight183 LB
-
-